Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Burden of HPV infection among Croatian women (CROSBI ID 579503)

Neobjavljeno sudjelovanje sa skupa | neobjavljeni prilog sa skupa | međunarodna recenzija

Cindrić, Anita ; Milutin Gašperov, Nina ; Sabol, Ivan ; Golubić Talić, Jasminka ; Grce, Magdalena Burden of HPV infection among Croatian women // ZIBI (Zentrum für Infektionsbiologie und Immunität) Summer Symposium 2011. "Poverty Related Diseases - a global challenge", the scientific meeting of the “Interdisciplinary Center for Infection Biology and Immunity" Berlin, Njemačka, 27.06.2011-28.06.2011

Podaci o odgovornosti

Cindrić, Anita ; Milutin Gašperov, Nina ; Sabol, Ivan ; Golubić Talić, Jasminka ; Grce, Magdalena

engleski

Burden of HPV infection among Croatian women

Cancer is a major concern in Croatia. Cervical cancer incidence rates decreased through years since the 1960s when opportunistic cervical cancer screening by Papanicolou (Pap) test was introduced in Croatia. However, mortality from cervical cancer in Croatia is higher than the average in the European Union. The crude incidence and mortality rates of cervical cancer in 2007 were 16.8 and 5.0 per 100, 000 women. High-risk Human papillomaviruses (HPV) are causing cervical cancer. The most common HPV types found in invasive cervical cancer collected worldwide were 16, 18, 31, 33, 35, 45, 52, and 58. In Croatia HPV 16, followed by 31, 52, 33, 18, 58 and 45, was found to be the most common HPV genotype in cervical smears among Croatian women with either low or high grade cervical lesions. The effective implementation of the organized cervical cancer screening programme, and in parallel, the HPV vaccination programme would be the only way to achieve further reduction of cervical cancer cases in Croatia. HPV DNA testing that is already widely used in clinical settings in Croatia, should become the primary screening test, while HPV genotyping of at least the most common types in invasive cervical cancer, HPV 16 and 18 should become an integral part of the diagnostic procedures.

HPV; cervical cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

nije evidentirano

nije evidentirano

Podaci o skupu

ZIBI (Zentrum für Infektionsbiologie und Immunität) Summer Symposium 2011. "Poverty Related Diseases - a global challenge", the scientific meeting of the “Interdisciplinary Center for Infection Biology and Immunity"

poster

27.06.2011-28.06.2011

Berlin, Njemačka

Povezanost rada

Temeljne medicinske znanosti